A new specific succinate-glutamate metabolomic hallmark in Sdhx-related paragangliomas

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Imperiale, Alessio ^a,b   Moussallieh, François Marie ^a,b   Sebag, Fréd́eric ^c   Brunaud, Laurent ^d   Barlier, Anne ^e   Elbayed, Karim ^b   Bachellier, Philippe ^a   Goichot, Bernard ^a   Pacak, Karel ^f   Namer, Izzie Jacques ^a,b   Taiëb, David ^c  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c TIMONE HOSPITAL   (France)

^d UNIVERSITY HOSPITAL OF NANCY   (France)

^e AIX MARSEILLE UNIVERSITY   (France)

^f EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMIC ACID; HUMANS; METABOLOMICS; MODELS, BIOLOGICAL; PARAGANGLIOMA; SUCCINATE DEHYDROGENASE; SUCCINIC ACID;

EID: 84894243707     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0080539     Document Type: Article

References (36)

1. Jafri M, Whitworth J, Rattenberry E, Vialard L, Kilby G, et al. (2013) Evaluation of SDHB, SDHD and VHL gene susceptibility testing in the assessment of individuals with non-syndromic phaeochromocytoma, paraganglioma and head and neck paraganglioma. Clinical endocrinology 78: 898-906.
2. Piccini V, Rapizzi E, Bacca A, Di Trapani G, Pulli R, et al. (2012) Head and neck paragangliomas: genetic spectrum and clinical variability in 79 consecutive patients. Endocr Relat Cancer 19: 149-155.
3. Timmers HJ, Gimenez-Roqueplo AP, Mannelli M, Pacak K (2009) Clinical aspects of SDHx-related pheochromocytoma and paraganglioma. Endocr Relat Cancer 16: 391-400.
4. Huang H, Abraham J, Hung E, Averbuch S, Merino M, et al. (2008) Treatment of malignant pheochromocytoma/paraganglioma with cyclophosphamide, vincristine, and dacarbazine: recommendation from a 22-year follow-up of 18 patients. Cancer 113: 2020-2028.
5. Isaacs JS, Jung YJ, Mole DR, Lee S, Torres-Cabala C, et al. (2005) HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability. Cancer Cell 8: 143-153.
6. Dang L, White DW, Gross S, Bennett BD, Bittinger MA, et al. (2009) Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462: 739-744.
7. Kaelin WG Jr, McKnight SL (2013) Influence of metabolism on epigenetics and disease. Cell 153: 56-69.
8. Letouze E, Martinelli C, Loriot C, Burnichon N, Abermil N, et al. (2013) SDH Mutations Establish a Hypermethylator Phenotype in Paraganglioma. Cancer Cell 23: 739-752.
9. Pollard PJ, Briere JJ, Alam NA, Barwell J, Barclay E, et al. (2005) Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations. Hum Mol Genet 14: 2231-2239.
10. Xiao M, Yang H, Xu W, Ma S, Lin H, et al. (2012) Inhibition of alpha-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors. Genes & development 26: 1326-1338.
11. Wishart DS (2013) Exploring the human metabolome by nuclear magnetic resonance spectroscopy and mass spectroscopy; Lutz NW, editor. Cambridge: Cambridge University Press.
12. Pope WB, Prins RM, Albert Thomas M, Nagarajan R, Yen KE, et al. (2012) Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy. Journal of neuro-oncology 107: 197-205.
13. Piotto M, Moussallieh FM, Imperiale A, Benahmed MA, Detour J, et al. (2013) Reproducible sample preparation and spectrum acquisition techniques for metabolic profiling of human tissues by proton high-resolution magic angle spinning nuclear magnetic resonance; Lutz NW, editor. Cambridge: Cambridge University Press. 627 p.
14. Meiboom S, Gill D (1958) Modified spin echo method for measuring nuclear relaxation times. The Review of scientific instruments 29: 688-691.
15. Martinez-Bisbal MC, Marti-Bonmati L, Piquer J, Revert A, Ferrer P, et al. (2004) 1H and 13C HR-MAS spectroscopy of intact biopsy samples ex vivo and in vivo 1H MRS study of human high grade gliomas. NMR in biomedicine 17: 191-205.
16. Wishart DS, Tzur D, Knox C, Eisner R, Guo AC, et al. (2007) HMDB: the Human Metabolome Database. Nucleic acids research 35: D521-526.
17. Rao JU, Engelke UF, Rodenburg RJ, Wevers RA, Pacak K, et al. (2013) Genotype-Specific Abnormalities in Mitochondrial Function Associate with Distinct Profiles of Energy Metabolism and Catecholamine Content in Pheochromocytoma and Paraganglioma. Clin Cancer Res 19: 3787-3795.
18. Beckonert O, Coen M, Keun HC, Wang Y, Ebbels TM, et al. (2010) High-resolution magic-angle-spinning NMR spectroscopy for metabolic profiling of intact tissues. Nature protocols 5: 1019-1032.
19. Sitter B, Bathen TF, Tessem MB, Gribbestad IS (2009) High-resolution magic angle spinning (HR MAS) MR spectroscopy in metabolic characterization of human cancer. Progress in nuclear magnetic resonance spectroscopy 54: 239-254.
20. Ebbels TMD, Cavill R (2009) Bioinformatic methods in NMR-based metabolic profiling. Progress in nuclear magnetic resonance spectroscopy 55: 361-374.
21. Picard RR, Cook RD (1984) Cross-Validation of Regression Models. Journal of the American Statistical Association 79: 575-583.
22. Xu QS, Liang YZ (2001) Monte Carlo cross validation. Chemometrics and Intelligent Laboratory Systems 56: 1-11.
23. Wishart DS, Jewison T, Guo AC, Wilson M, Knox C, et al. (2013) HMDB 3.0-The Human Metabolome Database in 2013. Nucleic acids research 41: D801-807.
24. Imperiale A, Elbayed K, Moussallieh FM, Reix N, Piotto M, et al. (2013) Metabolomic profile of the adrenal gland: from physiology to pathological conditions. Endocr Relat Cancer 20: 705-716.
25. Favier J, Briere JJ, Burnichon N, Riviere J, Vescovo L, et al. (2009) The Warburg effect is genetically determined in inherited pheochromocytomas. PLoS One 4: e7094.
26. Feichtinger RG, Zimmermann FA, Mayr JA, Neureiter D, Ratschek M, et al. (2011) Alterations of respiratory chain complexes in sporadic pheochromocytoma. Frontiers in bioscience 3: 194-200.
27. Reitman ZJ, Jin G, Karoly ED, Spasojevic I, Yang J, et al. (2011) Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome. Proc Natl Acad Sci U S A 108: 3270-3275.
28. van Nederveen FH, Gaal J, Favier J, Korpershoek E, Oldenburg RA, et al. (2009) An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis. The lancet oncology 10: 764-771.
29. Gill AJ, Benn DE, Chou A, Clarkson A, Muljono A, et al. (2010) Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes. Hum Pathol 41: 805-814.
30. Korpershoek E, Favier J, Gaal J, Burnichon N, van Gessel B, et al. (2011) SDHA Immunohistochemistry Detects Germline SDHA Gene Mutations in Apparently Sporadic Paragangliomas and Pheochromocytomas. J Clin Endocrinol Metab 96: E1472-1476.
31. Eisenhofer G, Lenders JW, Linehan WM, Walther MM, Goldstein DS, et al. (1999) Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2. N Engl J Med 340: 1872-1879.
32. Eisenhofer G, Pacak K, Huynh TT, Qin N, Bratslavsky G, et al. (2011) Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma. Endocr Relat Cancer 18: 97-111.
33. Eisenhofer G, Walther MM, Huynh TT, Li ST, Bornstein SR, et al. (2001) Pheochromocytomas in von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes. J Clin Endocrinol Metab 86: 1999-2008.
34. Burnichon N, Cascon A, Schiavi F, Morales NP, Comino-Mendez I, et al. (2012) MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma. Clin Cancer Res 18: 2828-2837.
35. Yang M, Pollard PJ (2013) Succinate: a new epigenetic hacker. Cancer Cell 23: 709-711.
36. Burgess DJ (2013) Metabolism: Epigenetic links to the web of Krebs. Nat Rev Cancer 13: 437.